MRSHMarsh McLennan
$197.52+7.0% 1Y
$197.52
$157.3252 weeks$199.31
MRSH as reported
Marsh McLennan reported $28.5B of revenue over the trailing twelve months, +7.6% on the year before. 10 reported series are charted on this page, each one as filed.
$28.5B
Revenue, trailing twelve months · to Q3 2026 · +7.6% against the twelve months before
- Net income
- $4.04B
Net income · −2.1% year on year · trailing twelve months to Q3 2026
- Free cash flow
- $4.15B
Free cash flow · −14% year on year · trailing twelve months to Q3 2026
- Operating margin
- 21%
Operating margin · trailing twelve months to Q3 2026
Details›
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $28.5B | +7.6% | Q3 2026 |
| Net income | $4.04B | −2.1% | Q3 2026 |
| EPS | $8.36 | +0.24% | Q3 2026 |
| Operating margin | 21% | n/a | Q3 2026 |
| Net margin | 14% | n/a | Q3 2026 |
| ROE | 27% | n/a | Q3 2026 |
| ROA | 6.8% | n/a | Q3 2026 |
| ROIC | 14% | n/a | Q3 2026 |
| Free cash flow | $4.15B | −14% | Q3 2026 |
| P/E | 23.6 | n/a | today |
Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.

Marsh McLennan (MRSH) · Revenue and profitRevenue and profitMarsh McLennan (MRSH)
RevenueNet incomeTrailing twelve months
Powered byryufin.com
On our screens:Stocks that buy back more than they dilute
Insurance Brokers
The closest names by size in the same industry